TRACT Therapeutics
Chicago
About TRACT Therapeutics
TRACT Therapeutics develops a novel approach for restoring immune balance in patients receiving a solid organ transplant or in patients suffering from an autoimmune disease. This therapeutic approach may potentially reduce the chance of organ rejection following a transplant or transfer a patient suffering from an autoimmune disease into a state of remission.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Last round: Series Unknown (Mar 2019)
- Website: tracttherapeutics.com
- Phone: (312) 815-8986
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/tract-therapeutics-117313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.